3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt

3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt Struktur
1797008-74-2
CAS-Nr.
1797008-74-2
Englisch Name:
3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt
Synonyma:
Cilostazol sodium impurity 2;Cilostazol Cilostazol sodium Impurity 2;3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt
CBNumber:
CB82700478
Summenformel:
C20H28N5NaO3
Molgewicht:
409.45779
MOL-Datei:
1797008-74-2.mol

3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt Eigenschaften

Sicherheit

3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

An impurity of Cilostazol (C441500) which is a potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and card iotonic properties in vivo.

3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5158 50
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44893 58
Santa Cruz Biotechnology Inc 021-60936350
scbt@scbt.com China 6594 58
Hangzhou Yiyun Guoke Biotechnology Co., Ltd. 17717523804
1211221625@qq.com China 8587 58

  • 3-(2-Amino-5-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)phenyl)propanoic Acid Sodium Salt
  • Cilostazol sodium impurity 2
  • Cilostazol Cilostazol sodium Impurity 2
  • 1797008-74-2
Copyright 2019 © ChemicalBook. All rights reserved